Business Description
Founded in 2016 and based in Chengdu, China, Keymed Biosciences is a drug development company focused on creating treatments for immune system disorders and cancer across China, the United States, and the United Kingdom. The company has built a broad pipeline of experimental medicines, including therapies for skin conditions, nasal polyps, blood disorders, tumors, and Alzheimer's disease, several of which are already in clinical trials. Keymed also partners with other companies through licensing agreements to extend the reach of its research.
